Recruiting
Phase 3

Atenativ

Sponsor:

Octapharma

Code:

NCT04918173

Conditions

Congenital Antithrombin Deficiency

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Atenativ

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-05. This information was provided to ClinicalTrials.gov by Octapharma on 2025-02-04.